Pluronic block copolymers inhibit low density lipoprotein self-association

Area of Science:

• Biochemistry
• Polymer Science
• Cardiovascular Research

Background:

• Exogenous inhibitors of low-density lipoprotein (LDL) aggregation are largely unknown.
• Inhibiting LDL aggregation may offer a therapeutic strategy against atherosclerosis.
• Amphiphilic copolymers, like Pluronic block copolymers, are potential candidates for modulating LDL aggregation.

Purpose of the Study:

• To investigate the effect of Pluronic block copolymers with varying hydrophilic-lipophilic properties on LDL aggregation.
• To determine if Pluronic block copolymers can serve as exogenous inhibitors of LDL aggregation.

Main Methods:

• Comparative study of Pluronic P85, L61, and F68 on LDL aggregation.
• Evaluation of Pluronic concentrations relative to their critical micelle formation concentrations.

Main Results:

• Hydrophobic Pluronic copolymers (P85 and L61) inhibited LDL aggregation at concentrations near or above their critical micelle concentration.
• The hydrophilic Pluronic F68 showed no effect on LDL aggregation.
• This is the first demonstration of Pluronic block copolymers inhibiting LDL self-association.

Conclusions:

• Pluronic block copolymers, particularly hydrophobic variants, can inhibit LDL aggregation.
• The ability to modulate LDL aggregation with Pluronics is a key step towards developing novel anti-atherosclerotic therapies.